logo
  

GM Receives $214.3 Mln Contract To Produce U.S. Army's Infantry Squad Vehicle

GM Defense LLC, a subsidiary of General Motors (GM), has received a contract from the U.S. Army to build, field and sustain the Army's new Infantry Squad Vehicle or ISV.

The total production ISV contract award value is $214.3 million to procure the initial Army Procurement Objective of 649. The approved Army Acquisition Objective is 2,065 vehicles, General Motors said in a statement.

Designed to provide rapid ground mobility, the expeditionary ISV is a light and agile all-terrain troop carrier intended to transport a nine-Soldier infantry squad moving throughout the battlefield. The ISV is light enough to be sling loaded from a UH-60 Blackhawk helicopter and compact enough to fit inside a CH-47 Chinook helicopter for air transportability, GM said.

According to the company, all ISV models will be equipped with an occupant and cargo superstructure powered by a 186-horsepower, 2.8L Duramax turbo-diesel engine, and six-speed automatic transmission.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning. Science and technology firm Danaher Corp. (DHR) announced Thursday that it has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance... Biopharmaceutical company Kite Pharma, a part of Gilead Sciences, Inc. (GILD), and biotechnology company Shoreline Biosciences, Inc. announced Thursday a strategic partnership to develop novel cell therapies across a variety of cancer targets. The partnership follows Kite's investment in Shoreline's...
Follow RTT